Lipoprotein(a) in Familial Hypercholesterolemia With Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) Gain-of-Function Mutations.
Hayato Tada, 研至 林, Ryota Teramoto(Ishikawa Prefectural Central Hospital), Masa‐aki Kawashiri(Kanazawa University), 了太 寺本, Atsushi Nohara(Kanazawa University), Tetsuo Konno(Kanazawa University), Taiji Yoshida(Kanazawa Hospital), 宏 馬渕, Akihiro Inazu, Kenshi Hayashi, 正和 山岸, Hiroshi Mabuchi, 明広 稲津, Masakazu Yamagishi, 隼人 多田, 淳 野原, 剛照 川尻
Cited by 0
Related Papers
Cardiac fibrosis in mice with hypertrophic cardiomyopathy is mediated by non-myocyte proliferation and requires Tgf-β
|Journal of Clinical Investigation|2010|440
T wave peak-to-end interval and QT dispersion in acquired long QT syndrome: a new index for arrhythmogenicity
|Clinical Science|2003|313
T‐peak to T‐end interval may be a better predictor of high‐risk patients with hypertrophic cardiomyopathy associated with a cardiac troponin i mutation than qt dispersion
|Clinical Cardiology|2002|267
Guidelines for Diagnosis and Treatment of Familial Hypercholesterolemia 2017
|Journal of Atherosclerosis and Thrombosis|2018|226
Guidelines for the Management of Familial Hypercholesterolemia
|Journal of Atherosclerosis and Thrombosis|2012|177